An update on the management of hepatitis C virus and human immunodeficiency virus co-infection

Bryan Tolentino; Ritu R. Singh; Suresh Misra; Douglas T. Dieterich; Dost Sarpel

doi:10.2217/fvl-2018-0116

An update on the management of hepatitis C virus and human immunodeficiency virus co-infection

Bryan Tolentino, Ritu R. Singh, Suresh Misra, Douglas T. Dieterich, Dost Sarpel

Research output: Contribution to journal › Review article › peer-review

Abstract

An estimated 2.3 million people globally are co-infected with HIV and HCV. Liver disease is now a leading cause of non-AIDS-related mortality among HIV-infected patients. The development of direct-acting antiviral agents has revolutionized the treatment of HIV/HCV co-infection with sustained virologic response response rates above 95% in most patient populations. This article provides an update on the management of acute and chronic HCV in patients co-infected with HIV including a section on drug-drug interactions.

Original language	English
Pages (from-to)	185-195
Number of pages	11
Journal	Future Virology
Volume	14
Issue number	3
DOIs	https://doi.org/10.2217/fvl-2018-0116
State	Published - 1 Mar 2019

Keywords

DAA
HCV
HIV
HIV-HCV interaction
acute HCV
chronic HCV
co-infection
direct-acting antivirals
drug interactions
interferon

Access to Document

10.2217/fvl-2018-0116

Cite this

@article{b66d40095ba14f1badc5c3d979b1b91c,

title = "An update on the management of hepatitis C virus and human immunodeficiency virus co-infection",

abstract = "An estimated 2.3 million people globally are co-infected with HIV and HCV. Liver disease is now a leading cause of non-AIDS-related mortality among HIV-infected patients. The development of direct-acting antiviral agents has revolutionized the treatment of HIV/HCV co-infection with sustained virologic response response rates above 95% in most patient populations. This article provides an update on the management of acute and chronic HCV in patients co-infected with HIV including a section on drug-drug interactions.",

keywords = "DAA, HCV, HIV, HIV-HCV interaction, acute HCV, chronic HCV, co-infection, direct-acting antivirals, drug interactions, interferon",

author = "Bryan Tolentino and Singh, {Ritu R.} and Suresh Misra and Dieterich, {Douglas T.} and Dost Sarpel",

note = "Publisher Copyright: {\textcopyright} 2019 Future Medicine Ltd.",

year = "2019",

month = mar,

day = "1",

doi = "10.2217/fvl-2018-0116",

language = "English",

volume = "14",

pages = "185--195",

journal = "Future Virology",

issn = "1746-0794",

publisher = "Future Medicine Ltd.",

number = "3",

}

TY - JOUR

T1 - An update on the management of hepatitis C virus and human immunodeficiency virus co-infection

AU - Tolentino, Bryan

AU - Singh, Ritu R.

AU - Misra, Suresh

AU - Dieterich, Douglas T.

AU - Sarpel, Dost

PY - 2019/3/1

Y1 - 2019/3/1

N2 - An estimated 2.3 million people globally are co-infected with HIV and HCV. Liver disease is now a leading cause of non-AIDS-related mortality among HIV-infected patients. The development of direct-acting antiviral agents has revolutionized the treatment of HIV/HCV co-infection with sustained virologic response response rates above 95% in most patient populations. This article provides an update on the management of acute and chronic HCV in patients co-infected with HIV including a section on drug-drug interactions.

AB - An estimated 2.3 million people globally are co-infected with HIV and HCV. Liver disease is now a leading cause of non-AIDS-related mortality among HIV-infected patients. The development of direct-acting antiviral agents has revolutionized the treatment of HIV/HCV co-infection with sustained virologic response response rates above 95% in most patient populations. This article provides an update on the management of acute and chronic HCV in patients co-infected with HIV including a section on drug-drug interactions.

KW - DAA

KW - HCV

KW - HIV

KW - HIV-HCV interaction

KW - acute HCV

KW - chronic HCV

KW - co-infection

KW - direct-acting antivirals

KW - drug interactions

KW - interferon

UR - http://www.scopus.com/inward/record.url?scp=85063300120&partnerID=8YFLogxK

U2 - 10.2217/fvl-2018-0116

DO - 10.2217/fvl-2018-0116

M3 - Review article

AN - SCOPUS:85063300120

SN - 1746-0794

VL - 14

SP - 185

EP - 195

JO - Future Virology

JF - Future Virology

IS - 3

ER -

An update on the management of hepatitis C virus and human immunodeficiency virus co-infection

Abstract

Keywords

Access to Document

Fingerprint

Cite this